Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion type Assertion NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_head.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion description "[Three months after initiation of TCZ therapy, changes in swollen joint count (SJC) and, subordinately, tender joint count (TJC), serum-CRP, DAS28-CRP, and EULAR-response were tested for association with the IL6R-haplotype or genotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_provenance.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion evidence source_evidence_literature NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_provenance.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion SIO_000772 24978393 NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_provenance.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion wasDerivedFrom befree-2016 NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_provenance.
- NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_assertion wasGeneratedBy ECO_0000203 NP1197127.RARAonZbreJsBPNkJ1-AY6yQCSRYvC7tqEw-_5joJxNj8130_provenance.